EWSR1/FUS–CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities
- 7 August 2020
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 33 (11) , 2233-2243
Abstract
No abstract availableKeywords
Funding Information
- Dahan Translocation Carcinoma Fund, Joey’s Wings
- Cycle for Survival, Kristin Ann Carr Foundation
This publication has 24 references indexed in Scilit:
- Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM FusionAmerican Journal of Surgical Pathology, 2019
- Molecular Profiling of Hyalinizing Clear Cell Carcinomas Revealed a Subset of Tumors Harboring a Novel EWSR1-CREM FusionAmerican Journal of Surgical Pathology, 2018
- A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 FusionsAmerican Journal of Surgical Pathology, 2017
- Tumors With EWSR1-CREB1 and EWSR1-ATF1 FusionsAmerican Journal of Surgical Pathology, 2012
- Primary Pulmonary Myxoid Sarcoma With EWSR1-CREB1 FusionAmerican Journal of Surgical Pathology, 2011
- EWSR1‐ATF1 fusion is a novel and consistent finding in hyalinizing clear‐cell carcinoma of salivary glandGenes, Chromosomes and Cancer, 2011
- Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts)Laboratory Investigation, 2009
- EWSR1‐CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytomaGenes, Chromosomes and Cancer, 2007
- EWS-CREB1: A Recurrent Variant Fusion in Clear Cell Sarcoma—Association with Gastrointestinal Location and Absence of Melanocytic DifferentiationClinical Cancer Research, 2006
- Molecular Diagnosis of Clear Cell SarcomaThe Journal of Molecular Diagnostics, 2002